IBM, Coriell Life Sciences and CareKinesis Deliver Personalized Medicine

LAS VEGAS – 29 Apr 2014: IBM (NYSE: IBM) today announced a collaboration with Coriell Life Sciences, a provider of genetic analysis at point of care, and CareKinesis, Inc., a Medication Risk Mitigation pharmacy services firm, to bring personalized medicine to the elderly based on analyzing and storing genetic data in a secure cloud environment. 
Read the full story here.